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Abstract: Aim: To discuss conflicts of interest and their impact on health care practice, policy and 
science. 
Methods: Selective literature review and own empirical studies.  
Results and conclusions: There is growing pressure on medical practitioners, researchers and policy 
makers to face up to the subject of conflicts of interest which is a very topical and controversial one in 
different areas of the health care system. Conflicts of interest are often unavoidable but there is 
nothing dishonourable about this and it does not in itself either detract from the value of the research 
and clinical work being done or impugn the integrity of the people doing it. However, the issue 
becomes critical when possible conflicts of interest are ignored. Inadequate awareness and 
transparency may cause substantial damage, both to the quality of research and clinical practice, and 
also to the reputations of individuals and of the medical profession and the scientific community as a 
whole. Therefore, to deal constructively with conflicts of interest we particularly need to enhance the 
awareness and transparency. 
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Abstract 
Aim: To discuss conflicts of interest and their impact on health care practice, policy 
and science.  
Methods: Selective literature review and own empirical studies.  
Results and conclusions: There is growing pressure on medical practitioners, 
researchers and policy makers to face up to the subject of conflicts of interest which 
is a very topical and controversial one in different areas of the health care system. 
Conflicts of interest are often unavoidable but there is nothing dishonourable about 
this and it does not in itself either detract from the value of the research and clinical 
work being done or impugn the integrity of the people doing it. However, the issue 
becomes critical when possible conflicts of interest are ignored. Inadequate 
awareness and transparency may cause substantial damage, both to the quality of 
research and clinical practice, and also to the reputations of individuals and of the 
medical profession and the scientific community as a whole. Therefore, to deal 
constructively with conflicts of interest we particularly need to enhance the 
awareness and transparency. 
Key words: conflicts of interest, health services research, public health, 
transparency 
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Text 
The subject of conflicts of interest is a very topical and controversial one in a number 
of different areas of the health care system. Examples of such areas are in-service 
training events for doctors that are sponsored by the pharmaceutical industry and 
visits to hospitals and doctors’ surgeries by industry representatives (Moynihan 2008; 
Carney et al. 2001; Wazana 2000). Links between medical research and related 
sectors of industry are also increasingly giving rise to critical debate both among 
professionals and in the public domain (Agnell 2000; DeAngelis 2006). There is 
growing pressure on medical practitioners, researchers and policy makers to face up 
to these issues.  
In the theoretical discussion within the sector, a distinction is made between primary 
and secondary interests. Primary interests relate to the fundamental concerns and 
objectives involved in the exercise of a profession (Thompson 1993). These vary, 
depending on what area of professional activity is involved in each case. For 
physicians engaged in clinical practice, for example, the primary interest as defined 
from this point of view is to provide the individual patient with the best possible 
treatment; for researchers it is to produce valid new results; while for politicians 
concerned with the organisation of health care it is to create a system providing the 
best possible framework of conditions. Secondary interests, on the other hand, relate 
to circumstances which have material or social consequences that might influence 
people’s judgments. This may express itself in many different ways, for example in 
the form of taking only one side of an argument into consideration, or of avoiding 
asking awkward questions, or else of not pursuing the search for scientific insights to 
sufficient depths (Klemperer 2008).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 3 
Such secondary interests do not automatically imply negative consequences. The 
quest for academic success (as measured by reputation, the number of publications 
and the ability to tap into new sources of funding) is a secondary interest among 
researchers which may initially be assumed to exert a positive influence on the 
primary scientific interest of gaining valid new findings. Practising physicians for their 
part draw a large proportion of their social status from the doctor/patient relationship; 
the enhancement of this status represents a secondary interest that is capable of 
influencing positively the basic concern of the medical practitioner to provide his 
patients with the best possible care. These examples show that primary and 
secondary interests are closely interlinked, and in the ideal case represent important 
drivers of progress, development and the quality of care.  
However, secondary interests may also have substantial negative consequences, 
and one essential aspect of the matter is the fact that we are often not aware of, or 
prefer to close our eyes to, this problem (DeAngelis 2006; Klemperer 2008; 
Schneider 2008).  
Lobbying activities 
As mentioned above, among the problematic areas is the influence of the 
pharmaceutical industry on research. For example, studies sponsored by the industry 
produce results favourable towards a particular product and a particular diagnostic or 
therapeutic procedure more frequently than do studies that are not sponsored by the 
industry (Bekelmann et al. 2003; Bell et al. 2006; Lexchin et al. 2003). This may be 
due, among other factors, to the choice of study design, the questions asked of the 
data collected or publication bias. Publication bias occurs when the publication of 
results depends on their nature and direction (Dickersin 1990). For example, positive 
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or statistically significant results are more likely to be published than negative or 
inconclusive findings (Dwan et al. 2008).   
Where researchers are heavily dependent on acquiring outside funding, this fact 
fosters a tendency to reach conclusions or publish results that will be popular with 
whoever is providing the funding. If the researcher receiving the funds knows what 
results will best suit the sponsor making them available, his desire and need for 
further finance and for follow-up projects may create dependencies which – 
consciously or unconsciously – influence the scientific work (Klemperer 2008).  
Another critical point is the closeness to the industry of those who write clinical 
guidelines. Choudry et al. (2002) showed that four out of five authors of such 
guidelines had links to the pharmaceutical industry; and of these four, two were even 
employees or consultants of companies whose preparations they recommended in 
their guidelines.  
Although the pharmaceutical industry is at the focus of the debate on conflicts of 
interest, these may also be triggered by other players such as the medical 
technology industry, professional associations, health insurance funds or government 
authorities. In view of the all-pervasiveness of lobbying activities in the health care 
sector, there are plenty of temptations at all levels – whether it is the clinical, the 
scientific or the political/organisational level – to succumb to influence or accept 
inducements.  
It will never be possible to avoid conflicts of interest. Cooperation between 
researchers and the pharmaceutical industry, for example, is unavoidable, and 
indeed in many cases is even desirable and necessary – e.g. for the acquisition of 
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research funding or to foster the transfer of research findings into clinical practice and 
the development of new products.  
Awareness and transparency 
There appears, however, to be a need for a cultural shift with regard to how to deal 
with this issue, a shift in the direction of an enhanced awareness of possible conflicts 
of interest and of transparency in respect of them.  
Awareness means above all that both clinicians and researchers should give real 
consideration to the problem of possible conflicts of interests and should not, as can 
still frequently be observed, dismiss it with a superficial, knee-jerk reaction. It is an 
element of good academic practice to consider one’s own position self-critically and 
to monitor the extent to which one is capable of forming independent judgments. It is 
up to researchers and practitioners to be aware of their responsibilities and to live out 
this awareness on the basis of the understanding they have of their own professional 
positions. It would be a dreadful thing if they were to be forced into giving the matter 
more serious consideration only by increased pressure from outside (from 
government, the media or the courts).  
Transparency can be enhanced by the disclosure of any potential conflicts of interest. 
In the academic world, the arrangement whereby publications are accompanied by a 
conflicts of interest statement is an important instrument pointing in this direction. The 
International Committee of Medical Journal Editors (ICMJE) has issued 
internationally recognised recommendations with regard to the criteria to be applied; 
these provide for information to be given not only on possible financial conflicts of 
interest, but on non-financial ones such as personal relationships, intellectual passion 
or scientific competition as well.  
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Even though an increasing number of scientific journals nowadays expect their 
authors to provide such details, the actual implementation is often still less than ideal. 
Martinson et al. (2005) found out that not properly disclosing involvement in firms 
whose products are based on one`s own relationship belongs to the top ten 
misbehaviours of scientists. Schneider et al. (2007) investigated the practice of 
disclosing conflicts of interest in German publications concerning health services 
research: a mere 9% of the articles investigated (11 out of 124 publications) provided 
the reader with information on possible conflicts. This was due to the fact that only 
58% (18 out of 31) of the journals concerned expected their authors to disclose 
conflicts of interest when submitting manuscripts; while even those magazines that 
expected such details from their authors often did not publish them, and so did not 
make them transparent to the reader. Furthermore, it was noticeable that where 
information on conflicts of interest was given, this related first and foremost to 
financial relationships, whereas non-financial conflicts of interest were largely 
ignored.  
This is doubtless due among other things to the fact that, compared with financial 
ones, intellectual and social conflicts of interest are more difficult to define, and also 
to the fact that they may impinge particularly closely to the personality and personal 
sphere of the scientist concerned. This may be illustrated by the following example: 
Recently, I reviewed a manuscript on new models of care for a specific group of 
patients. The authors had carried out a survey with physicians who were potential 
collaborators with the specific services to examine barriers, incentives, and the 
physicians` professional self-image regarding the new models of care. Some of the 
authors have participated in the establishment of the services which were subject of 
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the study and act as well known pacemakers in the field. In the manuscript they 
stated that there were no conflicts of interest.  
However, I wondered if possibly there were conflicts of interest due to intellectual or 
social reasons. In their response to my review the authors negated this and 
explained: “We  surely  have  conducted  our  research with  a  high  level  of  
personal  commitment  and  intellectual passion  –  for  us  a method  to  ensure  the  
quality,  profundity  and  complexity  required  for  a  scientific approach of the 
(medical) world.”  
It becomes clear how difficult it is in particular cases to decide if there were non-
financial circumstances that should be mentioned – or not – in a conflict of interest 
statement. On the one hand, obviously, non-financial conflicts can occur for a reason 
such as intellectual passion (ICMJE 2008); it might influence the researchers` 
judgments in planning and conducting a study and interpreting the results, e.g. in the 
form of avoiding asking awkward questions or taking only one side of an argument 
into consideration. On the other hand, however, a high level of intellectual passion is 
the basic motive for research; it is inherent to the scientific system. Is there any 
benefit if intellectual passion was declared in a conflict of interest statement? How to 
define standards?   
Overall, compared to financial relationships, demands for the disclosure of 
intellectual and social conflicts of interest are more likely to run into obstacles - 
although this is no grounds for not making the attempt to achieve a greater degree of 
awareness and openness. Self-critical and balancing consideration of these factors 
ought to be inherent in the academic process. This is particularly important as the 
modern scientist faces intensive pressure resulting from factors such as competition, 
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 8 
regulatory, social and managerial demands which result in various possibilities for the 
compromise of scientific integrity (Martinson et al. 2005).   
Dealing constructively with conflicts of interest  
In dealing constructively with the issue of conflicts of interest, it might be helpful to 
take the following to heart: conflicts of interest will often be unavoidable, both in the 
academic sphere and in clinical practice, but there is nothing dishonourable about 
this and it does not in itself either detract from the value of the work being done or 
impugn the integrity of the people doing it. But the issue becomes critical when 
possible conflicts of interest are ignored. Inadequate awareness and transparency 
may cause substantial damage, both to the quality of research and clinical practice, 
and also to the reputations of individuals and of the medical profession and the 
scientific community as a whole. 
Conflicts of interest 
The author declares that he has no conflict of interest.  
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